University of Pennsylvania

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).

1,423 total trials 199 currently recruiting 982 completed early-phase tilt top decile by trial count

University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.

University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.

Top-decile sponsor footprint

University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,423 total, page 16 of 29

COMPLETED NA

Mobile Devices as Educational Skin History Tools

NCT03419637

COMPLETED NA

Reducing UV Exposure to Prevent Skin Cancer: Message Development & Testing

NCT03201120

COMPLETED NA

Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake

NCT03337269

COMPLETED NA

Project LIFT - Promoting Healthy Behavior Through a Wearable Fitness Device and Financial Incentives

NCT03221465

COMPLETED

Trauma Induced Coagulopathy and Inflammation

NCT03128658

COMPLETED NA

Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence

NCT03021759

COMPLETED NA

Monitoring Neonatal Resuscitation Trial

NCT03256578

COMPLETED Phase 4

SSRI Effects on Depression and Immunity in HIV/AIDS

NCT02620150

COMPLETED

Muscle OXPHOS and Nutrient Homeostasis

NCT02920671

COMPLETED NA

Social Incentives to Improve Diabetes

NCT02961192

COMPLETED NA

Kinetic Anesthesia Device Study

NCT03344510

COMPLETED

Developing Enhanced Prediction Models

NCT02983812

COMPLETED Early Phase 1

Autologous CD4 T-Cells in HIV (C34-CXCR4)

NCT03020524

COMPLETED NA

Transcranial Magnetic Stimulation for Attention Deficit/Hyperactivity Disorder (ADHD)

NCT03663179

TERMINATED Phase 2

11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced Neuroinflammation

NCT02811744

TERMINATED Early Phase 1

Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)

NCT03060356

TERMINATED

Non-invasive Measurement of Cerebrovascular Reactivity After Traumatic Brain Injury

NCT02990078

COMPLETED NA

Ostomy Telehealth For Cancer Survivors

NCT02974634

COMPLETED NA

Development of a Tailored HIV Prevention Intervention for Young Men

NCT02842060

TERMINATED NA

Cryobiopsy Versus Forceps Biopsy for Pulmonary Lesions

NCT02983903

COMPLETED NA

Regeneron 1331 Kinetics Sub-Study HoFH

NCT04722068

COMPLETED

Graded TTCE for Post-Embolization PAVM Monitoring

NCT02936349

COMPLETED NA

The Impact of Rideshare Transportation Services on Appointment Adherence

NCT02955433

TERMINATED Phase 2

CART19 in Adult Patients With Minimal Residual Disease During Upfront Treatment for ALL

NCT02935543

TERMINATED NA

Single Shot vs Catheter Infraclavicular Brachial Plexus Block After Distal Radius Fracture Repair

NCT02744352

COMPLETED

The Effect of ECMO on the Pharmacokinetics of the Drugs and Their Clinical Efficacy

NCT03659513

COMPLETED NA

Reality Check: An HIV Risk Reduction Serial Drama

NCT03352219

COMPLETED Phase 4

Lifestyle Modification and Liraglutide

NCT02911818

COMPLETED NA

Perfusion Enhancement With Respiratory Impedance in Stroke (PERI-Stroke)

NCT03476954

COMPLETED

Trans-MAPP II Study of Urologic Chronic Pelvin Pain

NCT02898220

COMPLETED NA

Messages and Plans to Increase Gym Utilization

NCT02899559

COMPLETED NA

Remote Surveillance of Postpartum Hypertension

NCT03185455

COMPLETED Phase 1

Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release Syndrome

NCT02906371

COMPLETED NA

A Randomized Trial of Recruitment Strategies for Research Participation

NCT02697799

COMPLETED Phase 2

Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease

NCT02765256

COMPLETED Phase 2

Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF)

NCT02840799

COMPLETED NA

Steps to Eliminate Postoperative Problems

NCT02880176

TERMINATED NA

Impact of Transjugular Intrahepatic Portosystemic Shunts on Liver Stiffness

NCT03352882

COMPLETED

Cognition and Smoking Relapse (HCS)

NCT03169101

COMPLETED NA

Testing an Organizational Change Model to Address Smoking in Mental Healthcare

NCT02849652

COMPLETED

Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry

NCT02852252

COMPLETED Phase 4

Targeting Right Ventricle in Pulmonary Hypertension Gilead

NCT02829034

TERMINATED

[18F]FES PET/CT in PAH

NCT02899533

COMPLETED NA

Twitter and Diabetes

NCT02806700

COMPLETED NA

Twitter and CV Health

NCT02622256

COMPLETED

Biomarkers in Neural Disorders

NCT02761707

TERMINATED

Delirium, Intraoperative Cerebral Perfusion and EEG Abnormalities After Total Hip Arthroplasty

NCT02818764

TERMINATED Phase 2

CART-19 Post-ASCT for Multiple Myeloma

NCT02794246

COMPLETED

Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-EGFRvIII Gene-modified Cellular Therapy Products in Cancer Studies

NCT02666248

COMPLETED NA

Automated Hovering for Congestive Heart Failure Patients

NCT02708654

← Previous Page 16 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 182
Phase 2 157
Phase 3 43
Phase 4 87

What is open in the University of Pennsylvania pipeline

199 recruiting of 1,423 indexed (14% open); 982 completed (69%).

Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).

Top condition: Obesity (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.